Shares of Strides Pharma Science may attract buying interest, as its wholly-owned subsidiary Strides Pharma Global Pte Ltd, Singapore, has received USFDA approval for tetracycline hydrochloride capsules USP 250 mg and 500 mg. The drug is an antibiotic used to treat various bacterial infections of the skin, intestines, respiratory tract, urinary tract, genitals and lymph nodes. According to IQVIA MAT data, the US market for tetracycline hydrochloride capsules USP is about $16 million.
Stocks
USFDA nod may boost Strides Pharma
|
Updated on
March 05, 2020
Published on
March 04, 2020
Published on
March 04, 2020
USFDA nod may boost Strides Pharma
|
Updated on
March 05, 2020
Published on
March 04, 2020
Published on
March 04, 2020